Form CDC 57.124 CDC 57.124 Antimicrobial Use and Resistance (AUR): Pharmacy Date Mo

Form Approved

OMB No. 0920-0666

Exp. Date: xx/xx/20xx

Antimicrobial Use and Resistance (AUR): Pharmacy Data

Monthly Electronic Upload Specification Tables

These data will be collected in an aggregate monthly electronic file transfer from the facility to NHSN via Clinical Document Architecture (CDA).

Table 1. CDA File Descriptors

These data elements will be transmitted with each month’s report.

Variable Name

Description of Variable

orgid

NHSN Facility ID number

location

NHSN location code

month

Denominator month

year

Denominator year

createDate

Date the record was created

createUserID

The user that created the record

version

Version number of the software under which the data was collected

modifyDate

Date the record was last updated

modifyUserID

The user that last modified record

modifyVersion

Version number of the software under which the data was last updated

Table 2. Aggregate Patient Information

These data elements are aggregated to the location and facility wide inpatient level for each month.

Variable Name

Description of Variable

numDaysPresent

Total number of days present

numTherapyDays

Number of therapy days

numAdmissions

Number of admissions

Table 3. Aggregate Pharmacy Information

These data elements are obtained from the facility’s electronic medication administration record (eMAR) or bar coding medication administration (BCMA) and aggregated to the location and facility wide inpatient level for each month.

Variable Name

Description of Variable

Examples

drugIngredient

Antimicrobial ingredient

(see Table 3a)

routeDrugAdmin

Route of administration

Digestive tract, respiratory tract, intravenous route, intramuscular route

Table 3a. List of Antimicrobials Accepted

This is the list of antimicrobials currently accepted into NHSN as part of the antimicrobial use reporting.

Amantadine

Cefaclor

Ceftaroline

Clindamycin

Fluconazole

Micafungin

Piperacillin/ Tazobactam

Ticarcillin/ Clavulanate

Amikacin

Cefadroxil

Ceftazidime

Colistimethate

Fosfomycin

Minocycline

Polymyxin B

Tigecycline

Amoxicillin

Cefazolin

Ceftazidime/ Avibactam

Dalbavancin

Gemifloxacin

Moxifloxacin

Posaconazole

Tinidazole

Amoxicillin/ Clavulanate

Cefdinir

Ceftibuten

Daptomycin

Gentamicin

Nafcillin

Quinupristin/ Dalfopristin

Tobramycin

Amphotericin B

Cefditoren

Ceftizoxime

Delafloxacin

Imipenem/ Cilastatin

Nitrofurantoin

Rifampin

Vancomycin

Amphotericin B liposomal

Cefepime

Ceftolozane/ Tazobactam

Dicloxacillin

Isavuconazonium

Oritavancin

Rimantadine

Voriconazole

Ampicillin

Cefixime

Ceftriaxone

Doripenem

Itraconazole

Oseltamivir

Sulfamethoxazole/ Trimethoprim

Zanamivir

Ampicillin/ Sulbactam

Cefotaxime

Cefuroxime

Doxycycline

Levofloxacin

Oxacillin

Sulfisoxazole

Anidulafungin

Cefotetan

Cephalexin

Ertapenem

Linezolid

Penicillin G

Tedizolid

Azithromycin

Cefoxitin

Chloramphenicol

Erythromycin

Meropenem

Penicillin V

Telavancin

Aztreonam

Cefpodoxime

Ciprofloxacin

Erythromycin/ Sulfisoxazole

Meropenem/ Vaborbactam

Peramivir

Telithromycin

Caspofungin

Cefprozil

Clarithromycin

Fidaxomicin

Metronidazole

Piperacillin

Tetracycline

Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)). Public reporting burden of this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333 ATTN: PRA (0920-0666). CDC 57.124 v4, 9.2

Page 5 of 5